- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05756803
Changes in Penile Firmness With Low-Intensity Shockwave Therapy (LiST)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will enroll men between the ages of 18 and 65 with corporal cavernosal firmness on elastography. The participants study duration is 3 months long and includes eight visits at the study center. Study visits consist of physical exam, vital signs, questionnaires, blood draws, and administration of low-intensity shockware therapy (LiST).
Low intensity extracorporeal (i.e., outside the body) shockwave therapy (LiST) is a treatment that has been in use since 2010 and has become commonly used Internationally and in the United States since 2015. The device applies a low-intensity shockwave to the surface of the penis using an ultrasound gel as the coupling agent.
The study will evaluate changes in corporal cavernosal firmness and changes in penile vascular blood flow.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Great Neck, New York, United States, 11021
- Private Office
-
Lake Success, New York, United States, 11042
- The Smith Institute for Urology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Men aged 18-64
- Sexually active men and evidence of increased firmness on elastography during their standard evaluation for erectile dysfunction.
Exclusion Criteria:
- Within two weeks of Visit 1 using erectogenic medications including PDE5 inhibitors and/or penile injection therapy
- Presence of a penile implant.
- Presence of cardiac pacemaker or defibrillator
- Patients who are using devices which are sensitive to electromagnetic radiation.
- Screening ultrasound positive for testicular cancer
- Presence of untreated prostate cancer
- Patients with severe coagulation disorders
- Patient that in the opinion of the Principal Investigator would be non-compliant with the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low Intensity Acoustic Shockwave Therapy
The device applies a low-intensity shockwave to the surface of the penis using an ultrasound gel as the coupling agent.
The low-intensity shockwave therapy device will be used with the purpose of improving penile blood flow and restoring sexual function in men with impaired erectile function.
|
The study is being done to find out if low-intensity shockwave therapy can improve penile blood flow and restore sexual function in men with impaired erectile function.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate changes in corporal cavernosal firmness with Low-Intensity Acoustic Shockwave Therapy (LiST)
Time Frame: 12 Weeks
|
Change in corporal firmness (KPa) with Low-Intensity Acoustic Shockwave Therapy (LiST)
|
12 Weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-1144
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.